Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: December 2012
-
By Donald Zuhn — Reflecting upon the events of the past twelve months, Patent Docs presents its sixth annual list of top biotech/pharma patent stories. For 2012, we identified fifteen stories that were covered on Patent Docs last year that we believe had (or are likely to have) the greatest impact on biotech/pharma patent practitioners…
-
By Kevin E. Noonan — The Senate on Saturday passed an amended version (S. Amendment 3344) of H.R. 6621, Rep. Lamar Smith's bill "To correct and improve certain provisions of the Leahy-Smith America Invents Act and title 35, United States Code." In this version, the (in)famous, controversial and unnecessary provisions relating to so-called pending "pre-GATT"…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Eli Lilly and Company v. Kappos et al.1:12-cv-01491; filed December 26, 2012 in the Eastern District of Virginia Review and correction of the patent term adjustment calculation made by the U.S. Patent and Trademark Office…
-
January 2-5, 2013 – National CLE Conference (Law Education Institute, Inc.) – Snowmass, Colorado January 10, 2013 – China's Patent Regime and its Quest to Become an Innovation Economy (The George Washington University Law School and Fordham University School of Law) – Washington, DC January 22, 2013 – Top Patent Law Stories of 2012 (McDonnell…
-
IBC Legal will be holding its 21st annual Biotech & Pharmaceutical Patenting conference on February 26-27, 2013 in Munich, Germany. Conference highlights include: • Benefit from the latest trends in patent protection strategies and competitive patent filing;• Hear from WIPO, EPO, EC, industry players and the cream of legal advisors internationally;• Analyze recent cases and…
-
By Kevin E. Noonan — A generation ago, Jeremy Rifkin famously convinced the Cambridge city council to ban genetic engineering in that city, using the fear of "tinkering" with nature and producing a "superbug" that would hurt the public health and thereby (for a time) reduced progress in biological research at Harvard and elsewhere in…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office published a notice in the Federal Register (77 Fed. Reg. 75019) issuing the Office's final rule implementing the micro entity provision of § 10 of the Leahy-Smith America Invents Act. The notice concerns rules changes that provide procedures for claiming micro entity status,…
-
By Kevin E. Noonan — Last Friday, the White House released the names of the 2012 recipients of the National Medal of Science and the National Medal of Technology and Innovation. In the press release, the President said he was "proud to honor these inspiring American innovators" and that: They represent the ingenuity and imagination…
-
The authors and contributors of Patent Docs wish their readers and families a Happy Holidays. Publication of Patent Docs will resume on December 26th.
-
By Jon Gowshall — Over the past few years the UK patents courts have moved closer to the approach of the European Patent Office (EPO) on inventive step. In particular, the UK courts have started to acknowledge the importance of expectation of success when dealing with obviousness. A recent decision (MedImmune Limited v Novatris Pharmaceuticals…
Patent Docs 